| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |